MARKET

FWP

FWP

Forward Pharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

7.63
+0.10
+1.33%
After Hours: 7.93 +0.3 +3.93% 16:25 03/02 EST
OPEN
7.53
PREV CLOSE
7.53
HIGH
7.70
LOW
7.41
VOLUME
10.41K
TURNOVER
--
52 WEEK HIGH
12.72
52 WEEK LOW
4.610
MARKET CAP
51.82M
P/E (TTM)
-4.3846
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Friedreich Ataxia Drug Market Size, Share and Forecast 2020- 2027 By Ameco Research
pune, India, Sun, 21 Feb 2021 23:44:38 / Comserve Inc. / -- Friedreich Ataxia Drug market is segmented by Type, and by Application. Players, stakeholders,...
Comserve · 02/22 04:45
European ADRs Move Sharply Higher in Tuesday Trading
MT Newswires · 02/16 11:26
Friedreich Ataxia Drug Industry Size by Research, 2021 Global Business Opportunities, Top Manufacture, Business Revenue, Industry Growth, Industry Share Report, Covid-19 Impact Findings on Regional Analysis and Global Forecast to 2025
Feb 12, 2021 (The Expresswire) -- Global "Friedreich Ataxia Drug Market" 2021 Industry Research Report is an inside-out and expert examination on the flow...
The Express Wire · 02/12 05:51
MARA, GME, FRSX and ZOM among midday movers
Gainers: Live Ventures (LIVE) +87%.GameStop (GME) +63%.Exela Technologies (XELA) +51%.AMMO (POWW) +41%.Castor Maritime (CTRM) +35%.Acorda Therapeutics (ACOR) +32%.Root (ROOT) +32%.Ondas Holdings (ONDS) +30%.NuCana (NCNA) +26%.Foresight Autonomous (FRSX) +26%.Losers: Asia Pacific Wire & Cable (APWC) -27%.Zomedica (ZOM) -26%.Forward Pharma
Seekingalpha · 01/13 17:45
Acorda Therapeutics, NuCana leads healthcare gainers; Zomedica, Forward Pharma among major losers
Gainers: Acorda Therapeutics (ACOR) +45%, NuCana (NCNA) +26%, Synlogic (SYBX) +24%, Evoke Pharma (EVOK) +23%, Tiziana Life Sciences (TLSA) +14%.Losers: Zomedica (ZOM) -26%, Forward Pharma (FWP) -15%, Provention Bio (PRVB) -14%, Acutus Medical (AFIB) -13%, NovaBay Pharmaceuticals (NBY) -12%.
Seekingalpha · 01/13 16:01
Forward Pharma Announces Rescheduling Of EP2801355 Appeal Hearing To Sept. 6, 2021 Due To COVID-19 Restrictions
Forward Pharma Announces Rescheduling of the EP2801355 Appeal Hearing to September 6, 2021 due to COVID-19 Restrictions COPENHAGEN, Denmark, Jan. 12, 2021 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP)
Benzinga · 01/12 21:30
Forward Pharma Announces Rescheduling of the EP2801355 Appeal Hearing to September 6, 2021 due to COVID-19 Restrictions
Forward Pharma A/S (NASDAQ:FWP) ("we," "Forward" or the "Company"), today announced that due to ongoing precautionary measures against the spread of the novel coronavirus ("COVID-19"), the Technical Board of Appeal (the "TBA") of the European Patent Office...
GlobeNewswire · 01/12 21:30
Forward Pharma Announces Rescheduling of the EP2801355 Appeal Hearing to September 6, 2021 due to COVID-19 Restrictions
Forward Pharma A/S (NASDAQ:FWP) ("we," "Forward" or the "Company"), today announced that due to ongoing precautionary measures against the spread of the novel coronavirus ("COVID-19"), the Technical Board of Appeal (the "TBA") of the European Patent Office...
GlobeNewswire · 01/12 21:30
More
Forecast
EPSBVPSCFPS
Actual (K USD)
Estimate (K USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of FWP. Analyze the recent business situations of Forward Pharma through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average FWP stock price target is 37.00 with a high estimate of 37.00 and a low estimate of 37.00.
EPS
Institutional Holdings
Institutions: 20
Institutional Holdings: 986.20K
% Owned: 14.52%
Shares Outstanding: 6.79M
TypeInstitutionsShares
Increased
3
38.30K
New
1
-13.46K
Decreased
1
255
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
-2.09%
Pharmaceuticals & Medical Research
-0.90%
Key Executives
Chief Executive Officer
Claus Svendsen
Chief Financial Officer
Joel Sendek
Controller/Vice President
Thomas Carbone
Director/Chairman
Florian Schonharting
Director
Torsten Goesch
Director
Jan van de Winkel
Non-Executive Director
Duncan Moore
Non-Executive Director
Karen Smith
Independent Director
J. Kevin Buchi
  • Dividends
  • Splits
  • Insider Activity
Declaration Date
Dividend Per Share
Ex-Div Date
--
Dividend USD 23.123008
09/12/2017
About FWP
Forward Pharma A/S is a Denmark-based bio-pharmaceutical company. It is developing a proprietary formulation of dimethyl fumarate (DMF), for the treatment of multiple sclerosis (MS) and other inflammatory and neurological indications. DMF is an immunomodulator that can be used as a therapeutic to improve the health of patients with MS and immune disorders .The Company is headquartered in Copenhagen, Denmark.

Webull offers kinds of Forward Pharma A/S stock information, including NASDAQ:FWP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FWP stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading FWP stock methods without spending real money on the virtual paper trading platform.